Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 654

1.

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.

Lepore G, Dodesini AR, Nosari I, Trevisan R.

Diabetes Care. 2003 Apr;26(4):1321-2. No abstract available.

PMID:
12663625
[PubMed - indexed for MEDLINE]
2.

Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

Diabetes Care. 2009 Jul;32(7):1170-6. doi: 10.2337/dc08-1874. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944.

PMID:
19389820
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
[PubMed - indexed for MEDLINE]
4.
5.

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

Albright ES, Desmond R, Bell DS.

Diabetes Care. 2004 Feb;27(2):632-3. No abstract available.

PMID:
14747268
[PubMed - indexed for MEDLINE]
6.

Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.

Deiss D, Kordonouri O, Hartmann R, Hopfenmüller W, Lüpke K, Danne T.

Pediatr Diabetes. 2007 Jun;8(3):157-62.

PMID:
17550426
[PubMed - indexed for MEDLINE]
7.

Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

Diabetes Technol Ther. 2007 Aug;9(4):339-47.

PMID:
17705689
[PubMed - indexed for MEDLINE]
8.

Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes.

Parkner T, Laursen T, Vestergaard ET, Hartvig H, Smedegaard JS, Lauritzen T, Christiansen JS.

Diabet Med. 2008 May;25(5):585-91. doi: 10.1111/j.1464-5491.2008.02418.x.

PMID:
18445172
[PubMed - indexed for MEDLINE]
9.
10.

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

Diabetes Technol Ther. 2005 Aug;7(4):587-96.

PMID:
16120030
[PubMed - indexed for MEDLINE]
11.

Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.

Bragd J, von Döbeln A, Lins PE, Adamson U, Bergström J, Oskarsson P.

Diabetes Technol Ther. 2010 Sep;12(9):689-93. doi: 10.1089/dia.2010.0062.

PMID:
20687863
[PubMed - indexed for MEDLINE]
12.

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B.

Diabetes Care. 2004 Nov;27(11):2590-6.

PMID:
15504991
[PubMed - indexed for MEDLINE]
13.

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

Diabetes Care. 2005 Mar;28(3):533-8.

PMID:
15735183
[PubMed - indexed for MEDLINE]
14.

Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.

Cohen D, Weintrob N, Benzaquen H, Galatzer A, Fayman G, Phillip M.

J Pediatr Endocrinol Metab. 2003 Sep;16(7):1047-50. No abstract available.

PMID:
14513883
[PubMed - indexed for MEDLINE]
15.

Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, Fradin S, Reznik Y.

Horm Metab Res. 2007 Mar;39(3):224-9.

PMID:
17373639
[PubMed - indexed for MEDLINE]
16.

Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients.

Lepore G, Dodesini AR, Nosari I, Trevisan R.

Diabetes Care. 2005 Jul;28(7):1834-5. No abstract available.

PMID:
15983352
[PubMed - indexed for MEDLINE]
17.

Continuous subcutaneous insulin infusion therapy: effects on quality of life.

Scheidegger U, Allemann S, Scheidegger K, Diem P.

Swiss Med Wkly. 2007 Aug 25;137(33-34):476-82.

PMID:
17990132
[PubMed - indexed for MEDLINE]
Free Article
18.

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.

Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.

Diabet Med. 2004 Nov;21(11):1213-20.

PMID:
15498088
[PubMed - indexed for MEDLINE]
19.

Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.

Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.

Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):378-85. doi: 10.1055/s-0029-1225337. Epub 2009 Jul 23.

PMID:
19629931
[PubMed - indexed for MEDLINE]
20.

Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.

Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M.

Arch Pediatr Adolesc Med. 2004 Jul;158(7):677-84.

PMID:
15237068
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk